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Abstract
Streptococcus suis serotype 2 is the main cause of zoonotic S. suis infection despite the fact that other serotypes are
frequently isolated from diseased pigs. Studies comparing concurrent invasive human and pig isolates from a single
geographical location are lacking. We compared the population structures of invasive S. suis strains isolated between 1986
and 2008 from human patients (N=24) and from pigs with invasive disease (N=124) in the Netherlands by serotyping and
multi locus sequence typing (MLST). Fifty-six percent of pig isolates were of serotype 9 belonging to 15 clonal complexes
(CCs) or singleton sequence types (ST). In contrast, all human isolates were of serotype 2 and belonged to two non-
overlapping clonal complexes CC1 (58%) and CC20 (42%). The proportion of serotype 2 isolates among S. suis strains
isolated from humans was significantly higher than among strains isolated from pigs (24/24 vs. 29/124; P,0.0001). This
difference remained significant when only strains within CC1 and CC20 were considered (24/24 vs. 27/37,P=0.004). The
Simpson diversity index of the S. suis population isolated from humans (0.598) was smaller than of the population isolated
from pigs (0.765, P=0.05) indicating that the S. suis population isolated from infected pigs was more diverse than the S. suis
population isolated from human patients. S. suis serotype 2 strains of CC20 were all negative in a PCR for detection of genes
encoding extracellular protein factor (EF) variants. These data indicate that the polysaccharide capsule is an important
correlate of human S. suis infection, irrespective of the ST and EF encoding gene type of S. suis strains.
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Introduction
Streptococcus suis is an emerging human pathogen. The number of
human S. suis infections reported worldwide has increased
significantly in the past years, with most cases originating in
Southeast Asia [1]. Human S. suis infection is acquired through
exposure to contaminated pigs or pig derived products. Meningitis
and sepsis are the most common clinical manifestations of S. suis
infections; hearing loss is a frequent complication [1].
S. suis infections are causing huge losses in pig production
worldwide. Although multiple putative virulence factors of S. suis
have been identified [2,3,4,5], including the polysaccharide
capsule [6,7], none of these have been shown to be essential for
infection. The epf gene encoding Extracellular Protein Factor (EF),
is a virulence-associated gene and is used as a virulence marker
although an epf mutant was not severely attenuated in virulence in
experimental infection [8,9]. Repeats-containing variants of this
gene (epf*, encoding EF*) were found in non-pathogenic or weakly
pathogenic strains [10]. In addition, Muramidase Released
Protein (MRP) and the hemolysin (suilysin), have been used as
virulence markers [8,11].
Healthy pigs can carry multiple serotypes of S. suis in their nasal
cavities, tonsils, and upper respiratory, genital and alimentary
tracts. Of the 33 serotypes, serotypes 1–9 and 14 are most
commonly associated with clinical infections in pigs [12,13].
Across the infectious serotypes, differences in virulence can be
observed under experimental conditions. Thus, serotype 2 is
considered to be more pathogenic for pigs than serotype 9 [14].
However, the latter serotype is endemic in the pig population
causing clinical illness under conditions such as stress and
suboptimal farm management, in certain geographical areas
[12]. S. suis serotype 2 is the most common cause of S. suis
infection in humans, in contrast to the situation in pigs. Serotypes
1, 4, 14 and 16 have been reported in a limited number of patients
only [1]. It is unknown why isolates with serotypes which are
highly prevalent amongst diseased pigs, such as serotypes 7 and 9,
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possible explanation for this observation is the lack of human
exposure to strains with serotypes 7 and 9 due to a much higher
prevalence of serotype 2 strains in pigs in geographical areas where
humans are highly exposed. However, another plausible explana-
tion is that humans are more susceptible to infection with serotype
2 strains than to infection with strains of serotypes 7 or 9.
Multi Locus Sequence Typing (MLST) is a recognized tool for
characterization of bacterial population structures. A MLST
scheme was designed for S. suis [15], and the currently available
comprehensive data set indicates that strains belonging to clonal
complex 1 (CC1), which includes sequence type 1 (ST1), are
associated with invasive disease in both pigs and humans. Other
CCs including invasive strains isolated from both humans and pigs
include CC25, CC28, and CC104 [16,17].
S. suis infection is a well recognized problem within the pork-
rearing industry in the Netherlands [18]. In addition, human
cases of S. suis infection occur regularly in the Netherlands
albeit at a very low frequency [19,20,21]. Surveillance of S. suis
infections and storage of bacterial isolates for both animals and
humans are centralized. The combined sets of stored invasive
isolates provide a unique opportunity to study and compare the
population structures of S. suis strains isolated from humans and
pigs with invasive disease in a single geographical area in order
to identify differences across S. suis strains infecting humans and
pigs.
Materials and Methods
Bacterial Strains
All isolates cultured from cerebrospinal fluid or blood from
patients with bacterial meningitis in the Netherlands are submitted
to the National Reference Laboratory of Bacterial Meningitis
(NRLBM) at the Academic Medical Centre, University of
Amsterdam, for further typing and storage, as part of the
continuous surveillance of bacterial meningitis in the Netherlands.
For this study the isolates were anonymized. Additional institu-
tional review board approval is not required for studying
anonymized submitted strains without patients data.
All S. suis strains, isolated from cerebrospinal fluid or blood of
human patients between 1986 and 2007, which were available at
the NRLBM, were included in the study.
S. suis isolates from pigs were obtained from samples sent to
the Animal Health Service, Deventer, or the Veterinary
Microbiological Diagnostic Center of the Faculty of Veterinary
Medicine, Utrecht in the Netherlands. These samples were
submitted by veterinary practitioners for diagnosis of S. suis
infection. Anonymized non-duplicate invasive S. suis isolates
isolated in the period 1996–2008, were used in this study. A
representative sample of each year from a total number of 2773
strains was obtained by choosing every 20
th isolate irrespective
of source or serotype. S. suis isolates obtained from pigs were
defined as invasive if they were cultured from brain tissue,
cerebrospinal fluid, blood, or joints from pigs with clinical
disease compatible with S. suis infection.
Strains were identified using Gram-stain, catalase test and
API20Strep (bioMerieux). Serotyping was performed using PCR
for detection of serotypes 1 (and 14), 1/2 and 2, 7, and 9 as
described by Wisselink and colleagues [22], including positive and
negative control strains, and by slide agglutination using serotype
specific antibodies for strains which were untypeable by PCR
(H. Smith, Central Veterinary Institute, Lelystad, The Nether-
lands).
Multi Locus Sequence Typing
Multi Locus Sequence Typing (MLST) was performed as
described by King et al. [15]. The nucleotide sequences of 7
housekeeping genes were generated by PCR and sequencing,
using primers as described in the S. suis MLST scheme, and the
sequence type (ST) was determined on the basis of the S. suis
MLST database available at www.mlst.net. To identify clonal
complexes, i.e groups of related genotypes (STs), isolates were
grouped with all isolates present in the S. suis database using the
eBURST algorithm (http://eburst.mlst.net) with the software
provided by the MLST website. Clonal complexes consisted of
sequence types that shared 6 of 7 alleles with at least 1 other
sequence type in the complex and named after the putative
founder (i.e. the ST that has the greatest number of single-locus
variants) of the group or after the most frequent ST of the group.
Sequence types that did not group with other sequence types in the
database were defined as singletons. For calculation of the genetic
diversity amongst isolates cultured from humans or from pigs, the
Simpson’s index of diversity was used, D~f 1{
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i~1
ni(ni{1)
N(N{1)
0
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where ni is the number of strains belonging to i
th type and N is the
total number of strains in the sample population [23].
Phylogenetic Analyses
A distance matrix in Nexus format was generated from the set of
allelic profiles using SplitsTree at http://pubmlst.org/analysis/.
This file was then used for phylogenetic analyses in SplitsTree 4.0,
by generating a Neighbor-Joining tree [24].
epf gene Typing
The presence of the epf gene, and its larger size variants
designated epf* encoding EF or EF*, was determined for all strains
isolated from human patients using PCR, as described by
Wisselink et al. [22].
Results
Human Isolates
During the period 1986–2007, 24 S. suis isolates obtained from
human patients with meningitis were submitted to the NRLBM.
Submitted isolates were equally distributed over time and
originated from multiple provinces with a high pig density,
throughout the country. All patients were male and were aged
between 27 and 66 years. Exposure to pigs or pork was confirmed
for 15 (63%) of patients, 14 of whom were keeping pigs or were
working in slaughterhouses.
All 24 human strains were identified as serotype 2 strains using
PCR, with a PCR product of the expected size for serotype 2 and a
negative PCR for detection of serotype 1 (Table 1 and
supplementary Table S1). MLST identified two distinct popula-
tions. One group of 12 strains (50%) was assigned to ST1 (CC1)
whilst the other group of 10 strains (42%) to ST20 (CC20). Two
strains were assigned new sequence types (ST134, ST146) on the
basis of sequence variation within a single locus when compared
with allele sequences of ST1 (single locus variants). Strains of ST1
and ST20 were equally distributed over time without clustering.
All strains with ST1 or single locus variants of ST1 were positive
in the PCR for detection of the epf gene. Ten strains carried the epf
gene and 4 strains the epf* gene. All strains with ST20 were
negative in this PCR.
S. suis in Humans and Pigs, the Netherlands
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A total of 130 pig isolates were obtained from the collection.
Six strains did not yield the expected PCR products in the
MLST assays and were excluded from further analysis. S. suis
strains isolated from pigs had a much more diverse serotype
distribution than strains isolated from humans (Table 1 and
Table S1). Serotype 9 was the predominant serotype. Amongst
124 pig isolates, 70 (56%) had serotype 9 and 29 (23%) serotype
2( p ,0.001, x2 test; human vs pig strains for serotype 2).
Sequence typing showed more diversity for pig isolates than
for human isolates. Of 124 strains typed by MLST, 53 (43%)
had ST16 and 28 (23%) had ST1. ST20 was found in only 3
strains isolated from pigs (p,0.001, Fisher’s exact test; human
vs pig strains for ST20). A new ST was defined for each of 19
pig isolates (Table S1). The higher number of genotypes (STs)
and CCs among S. suis strains isolated from pigs indicated that
the S. suis population isolated from infected pigs was more
diverse than the S. suis population isolated from human patients.
Comparison of diversity of the S. suis populations isolated from
pigs and humans using the Simpson’s diversity index, showed a
significant difference for both STs (0.775 and 0.598, respective-
ly, P=0.05; T-test) and CCs (0.648 and 0.507, respectively;
P=0.05; T-test).
Association between Genotype and Serotype
To assess the clonal complex distribution among the Dutch
isolates, isolates were grouped with all isolates (823 isolates on
August 2, 2011) present in the MLST database at http://ssuis.
mlst.net/, using ST profiles in an eBURST analysis (Figure 1).
Among 148 isolates, comprising 30 unique STs, 6 clonal
complexes were identified. CC1, CC13, CC16, CC20, CC25
and CC27 comprised 44, 4, 67, 17, 6 and 1 isolates, respectively
(Table 1, Table S1). The remaining 9 isolates were singletons. Of
124 pig isolates, 67 (54%) were of CC16. Human isolates were
only seen in CC1 and CC20. Among human isolates the
proportion of isolates belonging to CC1 (58%) or to CC20
(42%) was significantly higher than among pig isolates, (24%,
p,0.002, x2 test; and 6% (p,0.0001, Fisher exact test;
respectively).
The distribution of clonal complexes across the different
serotypes is shown in Table 1 and supplementary Table S1. Of
44 CC1 isolates, 38 (86%) were of serotype 2, 3 of serotype 1, 1 of
serotype 1/2 and 2 of serotype 9. Of 17 CC20 isolates, 13 (76%)
were of serotype 2, 3 of serotype 4, and one of serotype 9. The vast
majority of CC16 isolates (all from pigs) were of serotype 9 (62/67;
93%), 2 were serotype 3, one serotype 7 and two serotype 8.
Thus the two major serotypes 2 and 9 were distributed over
multiple generally non-overlapping clonal complexes. Serotype 2
strains were found in CC1 (38/53; 72%), CC20 (13/53; 25%),
CC27 (1/53; 2%) and CC29 (1/53; 2%). Serotype 9 comprised
isolates of CC1 (2/70; 3%), CC16 (62/70; 89%), and CC20 (1/70;
1%), as well as 5 (7%) singletons.
The proportion of serotype 2 strains among S. suis strains
isolated from humans was significantly higher than among strains
from pigs (24/24 vs 29/124; P,0.001). This difference remained
significant when only strains belonging to CC1 and CC20 were
considered. Amongst CC1 and CC20 strains, all 24 strains (100%)
isolated from humans were of serotype 2, compared with 27 of 37
(73%) pig strains (P=0.004; Fisher’s exact).
Phylogenetic Analysis
A Neighbor-Joining cluster analysis of allelic profiles using
SplitsTree4 showed groups corresponding with clonal complexes
identified with eBURST (Figure 2). Again, clusters comprised
multiple STs as well as serotypes. Moreover, some STs were
associated with multiple serotypes.
Discussion
We observed significant differences between the S. suis
populations isolated from human patients and from diseased pigs
in the Netherlands. Whilst serotype 9 was predominant amongst
invasive pig isolates, serotype 2 was responsible for all human
infections, during the same time period. In case series and other
reports on S. suis infections in humans, serotype 2 strains were
responsible for more than 95% of infections [1]. Limited data are
available on the prevalence of serotype 2 and other serotypes in
the pig populations in areas where most human infections occur,
such as in Vietnam and Thailand. A high prevalence of invasive
Table 1. Distribution of Streptococcus suis isolates among patients and pigs in the Netherlands, according to serotype and
genotype.
Genotype (Clonal Complex)
host serotype 1 13 16 20 25 27 Singleton total
human 2 14 10 24
pig 1 3 4 7
1/2 1 12
22 4 3 1 2 8
32 2
43 3
71 5 3 9
82 2
92 6 2 1 5 7 0
NT 11
All 44 4 67 17 6 1 9 148
doi:10.1371/journal.pone.0033854.t001
S. suis in Humans and Pigs, the Netherlands
PLoS ONE | www.plosone.org 3 May 2012 | Volume 7 | Issue 5 | e33854serotype 2 strains in the pig population may explain a
predominance of these strains as a cause of zoonotic infections.
Indeed, in a study on the characteristics of invasive strains isolated
from diseased pigs in China, the most prevalent serotype was
serotype 2, followed by serotype 3 [25], supporting this view. In
addition, serotype 2 was the most prevalent serotype carried in the
tonsils of healthy slaughterhouse pigs in Vietnam [26]. In contrast,
serotype 9 was the most prevalent serotype in diseased pigs in our
study performed in the Netherlands, but this serotype was not
isolated from human patients. Data on the prevalence of serotype
2 and serotype 9 strains in healthy pigs in the Netherlands are not
available. However, since serotype 2 is considered more virulent
than serotype 9 [14], one would expect this serotype to be isolated
more frequently from diseased pigs than serotype 9 strains if
serotype 2 was more prevalent than serotype 9 in the healthy pig
population.
The number of human strains studied is relatively small
compared with the number of pig strains. In addition, invasive
pig strains were isolated in a period only partly spanning the
period in which human strains were isolated (1996 to 2007 vs 1986
to 2007). We analyzed the distribution of genotypes of the human
isolates in time and found similar distributions in the two periods
1986 to 1995 (6 strains each CC1 and CC 20) and 1996 to 2007
(8 strains CC1, 4 strains CC20, Fisher’s exact test not significant).
The population of invasive pig S. suis strains was more diverse than
that of S. suis isolated from human patients as indicated by the
estimated Simpson’s diversity indices, suggesting selection in
the transmission from pigs to human. Human patients in the
Netherlands appear to be infected by only two, distinct, clonal
complexes of S. suis. Whilst each of these clonal complexes is
associated with multiple serotypes, human patients were infected
only by S. suis serotype 2. The structure of the serotype 2 capsular
polysaccharide of S. suis was recently determined. The backbone
sequence was found to be identical to that of Streptococcus agalactiae
type VIII and Streptococcus pneumoniae type 23F, whilst the repeating
unit contained a terminal 2,6-linked sialic acid molecule. Bacterial
capsular sialic acid has been shown to contribute to immune
evasion in a number of pathogens [27,28]. Although reports on the
possible role of sialic acid in porcine disease pathogenesis during S.
suis infection were inconclusive [29,30], it is tempting to speculate
on the role of capsular sialic acid in human S. suis infection.
Strikingly, the only other serotype of S. suis increasingly found to
infect humans, albeit at low numbers, is serotype 14 [31,32,33],
which was shown to also contain genes involved in sialic acid
synthesis, in contrast to serotype 7 and 9 strains [34]. Serotype 14
strains were not observed in our study. Although the capsule of
serotype 1 also contains sialic acid [34], human infection with
S. suis of serotype 1 has only been reported once [35]. In our study,
7/124 (6%) of the porcine isolates were of serotype 1 making
transfer from pigs to human less likely than that of serotype 2
isolates (29/124 [23%]).
EF, encoded by the epf gene, is associated with but not essential
for virulence. Similarly, other proteins, such as Muramidase
Released Protein (MRP) and the hemolysin (sly) have been
associated with virulence and these proteins are now often used as
markers to differentiate virulent and less-virulent strains. Amongst
the serotype 2 strains which were isolated from human patients,
those with ST20 (CC20) were negative in a PCR for detection of
the epf gene or its high molecular weight variants, as opposed to
the strain belonging to CC1. This indicates that EF is not required
for S. suis serotype 2 invasive disease caused by ST20 strains in
human patients and suggests that the presence of these genes is
associated with the genotype.
Figure 1. Combined eBURST analysis of the entire S. suis MLST database (accessed on 2 August 2011) and the complete collection
of strains isolated from pigs and humans with invasive S. suis infection described in this study. Clonal complexes and the predicted
founder STs are indicated by blue dots. Secondary founders are indicated by yellow dots. The size of the dots is relative to the number of isolates with
the respective ST present in the combined databases. Numbers in magenta correspond to the STs of the Dutch isolates in this study. Clonal
complexes relevant to this study are circled and labeled. Isolates cultured from human patients in this study are of CC1 (ST1, ST134 and ST148); and of
CC20 (ST20).
doi:10.1371/journal.pone.0033854.g001
S. suis in Humans and Pigs, the Netherlands
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were of ST1, ST134 or ST146 (CC1), and of ST20 (CC20). Whilst
ST1 is known to contain virulent strains which occur worldwide,
invasive isolates with ST20 have not been described before. One
isolate of serotype 9 (ST147, CC20) from a diseased pig appeared
to be a single locus variant of ST20. These findings, in addition to
the observation that multiple serotypes are found in CC16 and
CC1, indicate that capsule switch due to horizontal transfer of
capsule loci occurs rather frequently in S. suis, as was described
earlier by King and colleagues [15]. The high prevalence of
ST20/CC20 strains amongst the S. suis strains isolated from
humans in our study, as well as the recently reported strains of
clonal complex ST104 isolated from human patients in Thailand,
indicate that the population of S. suis serotype 2 strains infecting
humans is more diverse than previously suspected. Enhanced
surveillance of S. suis infections in humans may further increase
our knowledge on the population of S. suis causing zoonotic
infection.
Fifty-four percent of the S. suis isolates from pigs belonged to
CC16, while the remaining 42% were distributed over five clonal
complexes and 9 singletons. Serotypes within CC16 included
serotypes 9, 7, and 8. These data indicate that CC16 is another
clonal complex representing strains with invasive potential in pigs,
in addition to CC1, CC28 and CC25. The high prevalence of
ST16 strains in our study, which originated from different farms,
regions and were isolated in different years, resulted in ST16
becoming the founder of the CC16 (CC87) complex.
In summary, in this study from the Netherlands, humans were
infected by S. suis serotype 2 only, while serotype 9 was most
prevalent among diseased pigs. Human patients were infected by
Figure 2. Phylogenetic analyses of concatenated sequences of seven housekeeping gene fragments of Streptococcus suis strains
isolated from human patients and pigs in the Netherlands. The tree was constructed using Neighbor-Joining algorithm in SplitsTree4 using
MLST allelic profiles. Distance matrix was obtained from allelic profiles using the SplitsTree program at http://pubmlst.org/analysis/. ST’s comprising
the different clonal complexes are circled. Serotypes are indicated by coloured dots with a diameter corresponding to the number of strains. The
horizontal line indicates the scale for genetic distance in arbitrary units.
doi:10.1371/journal.pone.0033854.g002
S. suis in Humans and Pigs, the Netherlands
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contrast, strains belonging to CC16 were most frequently isolated
from infected pigs. Within CC1 and CC20, serotype 2 was
strongly associated with disease in humans. These data indicate
that the polysaccharide capsule is an important correlate of human
S. suis infection, irrespective of the ST and EF encoding gene type
of S. suis strains.
Supporting Information
Table S1 Characteristics of Streptococcus suis strains included in
the study.
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